Summer 2018 Library Location The Junior Board Cancer Resource Library (JBCRL) is located off the lobby in the East Pavilion, Room 1106 of the Helen F. Graham Cancer Center & Research Institute (HFGCC&RI) located on the Christiana Hospital campus Hours & Contact Monday through Friday 8:30 a.m. – 5:00 p.m. 302-623-4580 e-mail: [email protected]website: www.christianacare.org/cancerlibrary New! Clinical Books AJCC Cancer Staging manual American Cancer Society’s principle of oncology Cancer and exercise Clinical aromatherapy: essential oils in healthcare McWhinny’s textbook of family medicine MD Anderson Surgical Oncology Handbook ONS Guide to breast care for oncology nurses ONS Your guide to cancer prevention A practical guide to cancer systems biology Tumors and cancer: head-neck-heart-lungs-gut The Washington manual of hematology and oncology Join the library with your picture ID to borrow books, DVDs, CDs, Creative kits and receive a free library card and tote bag.
SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 2
Body | Mind | Wellness
Collection
Mind |Body |Wellness Collection includes DVDs, CDs,
and books on such topics as breathing well, relaxation,
yoga, meditation, mindfulness, walking, and much more.
New Movies
Babaziz – the prince who contemplated
his soul
Boo: A Madea Halloween
Daddy’s home
Diary of a mad black woman
A dog’s purpose
Downsizing
Forever my girl
Game night
Genius
Ghost goes West
Good deeds
Greatest showman
Jumanji: welcome to the jungle
Just getting started
Kingsman: the golden circle
Madea’s big happy family
The whales of August
Wonder
New Kid movies
An American Girl: Chrissa stands strong
The best of Gumby
The Cheetah Girls: 2
Disney Dogs 1
Ferninand
Princess Diaries 2
The Star
Molly: an American Girl: on the home
front
Creative Journaling at Home
Stop by the Library to participate in Creative
Journaling at home.
Participants can pick up prompts and start
creative journaling. This activity was developed
by Wendy Wallace, M.Ed., Healing Through Art
teacher.
Available to all. Visit Library for more details
SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 3
Consumer Health Books
New Arrivals
The adrenal thyroid revolution
Anticancer living
The breast cancer survival manual
Breasts: the owner’s manual
Childhood leukemia: a guide for families
PDR for nonprescription drugs
Essential herbs & natural supplements
The essential thyroid cookbook
Everything happens for a reason
Forks over knives: the cookbook
Inkspirations for breast cancer survivors
Male breast cancer: taking control
Mayo clinic the integrative guide to good health
Thinking through breast cancer: a philosophical exploration
Writing as a way of healing
Zumba: ditch the workout, join the party
Writing as Healing
Join us for a free two-hour workshop to explore
expressive and reflective writing with Joan
DelFattore, Ph.D., retired U of DE English
professor.
Each workshop is held the 2nd Monday of each
month (see dates below), 1:00 – 3:00 p.m.
Explore a different topic each month with Joan.
Call 302-623-4580. Materials are provided.
Open to all interested adults.
2018 Dates
July 9, 2018
August 13, 2018
September 10, 2018
October 8, 2018
November 12, 2018
December 10, 2018
The NEW
CRISPR Journal
SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 4
Look Good Feel Better is a free workshop offered
by caring, volunteer beauty professionals. They
teach women with cancer to manage the
appearance side effects of treatment including
instruction to address changes in skin, hair loss
and nails, as well as tips on wardrobe/styling.
To schedule your free workshop,
call 302-623-4580.
Expressive Art
with Georgia Jones
This program is ongoing and meets on the
2nd & 4th Friday of each month from 1-4 p.m.
Come relax with art. Gentle instruction will be
provided. Open to adults touched by cancer.
Materials are provided. Registration required by
calling 302-623-4714.
On Display at the Library
Photography by Dianne Carnegie. These
photographs are wildlife taken in the Galapagos
and in her yard. She is a member of the
Delaware Photographic Society.
New! In Print Journal
Lancet Oncology
Healing Through Art
A free art class is offered by Wendy Wallace, M.Ed., art teacher. Open to adults touched by cancer. Check monthly activity calendar for dates. Materials are provided. Registration requested.
(302) 623-4714.
SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 5
A091304: A Phase I/Randomized Phase II Study of MLN0128 vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma The objectives of the trial are: Primary Objective: --Primary Phase I objective To determine the safety and maximum tolerable dose of MLN0128 (TAK-228) within this patient population. Secondary Objective: --To evaluate adverse events. --To evaluate Overall Response Rate (ORR), Clinical Benefit Rate (CBR), and Duration of Response (DOR). --To evaluate Time to Progression (TTP) and Overall Survival (OS). Pre-Registration Eligibility Criteria (Step 0) --Central pathology review submission Registration Eligibility Criteria (Step 1) --Histologic Documentation and Measurable Disease --Prior Treatment ___ • Progression on at least one prior systemic chemotherapy for advanced, unresectable or metastatic disease. Prior adjuvant or neoadjuvant therapy is not included as prior systemic chemotherapy unless treatment occurred within the 6 months prior to study enrollment. ___ • There is no limit to the number of prior lines of treatment a patient has received. ___ • No treatment with biological therapy, immunotherapy, chemotherapy, investigational agent for malignancy, or radiation ≤ 28 days before study registration. No treatment with nitrosourea or mitomycin ≤ 42 days before study registration. ___ • No treatment with radiation therapy ≤ 28 days before study registration. ___ • Patients should have resolution of any toxic effects of prior therapy (except alopecia) to NCI CTCAE, Version 4.0, grade 1 or less. ___ • Prior treatment with pazopanib or any PI3K, mTOR, AKT, or dual PI3K/mTOR complex (TORC1/TORC2) inhibitors will be prohibited.
-- Age ≥18, ECOG performance status ≤ 1, and Not pregnant and not nursing --Parameter use for chronic concomitant treatment with proton pump inhibitors, treatment with strong inhibitors of
CYP3A4 inhibitors, or chronic concomitant treatment with strong CYP3A4 inducers. --Required Initial Laboratory Values Treatment: PHASE I ARM 1: TAK 228 30mg weekly till progression ARM 2: Pazopanib 800mg PO once daily (If progression occurs, may cross over to Arm 1)
For information regarding this clinical trial or if you would like to have the list of open protocols emailed to you, please call the Cancer Research Office
